Intelligent Bio Solutions Inc. (INBS)
Oxford Ledge is still expanding full research coverage of INBS. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
The company protects its technology through patents and trade secrets but faces significant challenges enforcing intellectual property rights globally and defending against competitors.
SEC filings
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-06-16
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-06-02
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-14
- 10-Q Quarterly financial report (unaudited) 2026-05-13
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-04-20
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for INBS. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open INBS in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.